Effectiveness and tolerability of second-line treatment with vildagliptin versus other oral drugs for type 2 diabetes in a real-world setting in the Middle East: results from the EDGE study

BACKGROUND: Type 2 diabetes mellitus (T2DM) is a chronic progressive disease that requires treatment intensification with antihyperglycemic agents due to progressive deterioration of β-cell function. A large observational study of 45,868 patients with T2DM across 27 countries (EDGE) assessed the eff...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Vasc Health Risk Manag
Hlavní autoři: Saab, Charles, Al-Saber, Feryal A, Haddad, Jihad, Jallo, Mahir Khalil, Steitieh, Habib, Bader, Giovanni, Ibrahim, Mohamed
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2015
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4348128/
https://ncbi.nlm.nih.gov/pubmed/25750538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S73703
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky